Page last updated: 2024-10-17

aminocaproic acid and Mycoplasma dispar Infection

aminocaproic acid has been researched along with Mycoplasma dispar Infection in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research Excerpts

ExcerptRelevanceReference
"Mycoplasma pneumoniae is a common cause of community-acquired infections of the human respiratory tract."1.46The surface-displayed chaperones GroEL and DnaK of Mycoplasma pneumoniae interact with human plasminogen and components of the extracellular matrix. ( Dumke, R; GrĂ¼ndel, A; Hagemann, L; Jacobs, E, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hagemann, L1
GrĂ¼ndel, A1
Jacobs, E1
Dumke, R1

Other Studies

1 other study available for aminocaproic acid and Mycoplasma dispar Infection

ArticleYear
The surface-displayed chaperones GroEL and DnaK of Mycoplasma pneumoniae interact with human plasminogen and components of the extracellular matrix.
    Pathogens and disease, 2017, 04-01, Volume: 75, Issue:3

    Topics: A549 Cells; Adenosine Triphosphatases; Aminocaproic Acid; Bacterial Proteins; Cell Membrane; Cell Su

2017